{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:37:45Z","timestamp":1757569065863,"version":"3.40.3"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":8235,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>The purpose of this investigation was to examine<jats:italic>in vivo<\/jats:italic>drug\u2010concentration anticonvulsant effect relationships of oxazepam in individual rats following administration of a single dose.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Whole blood concentration vs time profiles of oxazepam were determined following administration of doses of 4, 8 and 12 mg kg<jats:sup>\u22121<\/jats:sup>. The pharmacokinetics could be described by an open 2\u2010compartment pharmacokinetic model. Following 12 mg kg<jats:sup>\u22121<\/jats:sup>the values (mean \u00b1 s.e.,<jats:italic>n<\/jats:italic>= 11) of clearance and volume of distribution were 28 \u00b1 2 ml min<jats:sup>\u22121<\/jats:sup>kg<jats:sup>\u22121<\/jats:sup>and 2.6 \u00b1 0.31 kg<jats:sup>\u22121<\/jats:sup>, respectively, and were not significantly different from the values obtained at the other doses.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The anticonvulsant effect was quantitated by a new technique which allows repetitive determination of the convulsive threshold by direct cortical stimulation within one rat. Significant dose\u2010dependent elevations of the seizure threshold were observed.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>By pharmacokinetic\u2010pharmacodynamic modelling, a log\u2010linear relationship was found between concentration and anticonvulsant effect. Following 12 mg kg<jats:sup>\u22121<\/jats:sup>the values (mean \u00b1 s.e.,<jats:italic>n<\/jats:italic>= 11) of the pharmacodynamic parameters slope and minimal effective concentration (C<jats:sub>min<\/jats:sub>) were 243 \u00b1 27 \u03bcA and 0.11 \u00b1 0.02 mg l<jats:sup>\u22121<\/jats:sup>, respectively and not significantly different from the values obtained at the other doses.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>In a repeatability study the pharmacodynamic parameters were determined twice on two different occasions with an interval of two weeks in the same group of 11 rats. The inter\u2010animal variability in the pharmacodynamic parameter slope was 46%, whereas the intra\u2010animal variability was 24 \u00b1 18%. The value of the minimal effective concentration was in each animal and on each occasion close to zero within the relatively narrow range of 0.01\u20130.30 mgl<jats:sup>\u22121<\/jats:sup>.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The results of this study showed that it is possible to determine<jats:italic>in vivo<\/jats:italic>concentration\u2010anticonvulsant effect relationships of oxazepam under non\u2010steady\u2010state conditions in individual rats. The anti\u2010convulsant effect of oxazepam appeared to be a rapidly reversible direct effect and acute tolerance did not develop within the time frame of the experiments.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1990.tb14653.x","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T19:00:52Z","timestamp":1342724452000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phannacokinetic\u2010pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats"],"prefix":"10.1111","volume":"99","author":[{"given":"Jasper","family":"Dingemanse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob A.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariska W.E.","family":"Langemeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ineke","family":"Postel\u2010Westra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douwe D.","family":"Breimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Meinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meindert","family":"Danhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"volume-title":"Pharmaceutical Statistics","year":"1984","author":"BOLTON S.","key":"e_1_2_1_2_1"},{"doi-asserted-by":"publisher","key":"e_1_2_1_3_1","DOI":"10.1016\/S0140-6736(82)90059-9"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jn\/36.1.139","article-title":"The relation between starvation, metabolic acidosis and convulsive seizures in rats","volume":"36","author":"DAVENPORT V.D.","year":"1948","journal-title":"J. Nutr"},{"doi-asserted-by":"publisher","key":"e_1_2_1_5_1","DOI":"10.1016\/0163-7258(88)90101-5"},{"doi-asserted-by":"publisher","key":"e_1_2_1_6_1","DOI":"10.1007\/BF01062261"},{"doi-asserted-by":"publisher","key":"e_1_2_1_7_1","DOI":"10.1111\/j.2042-7158.1988.tb05301.x"},{"key":"e_1_2_1_8_1","first-page":"421","volume-title":"Psychotropic Drugs. Plasma Concentration and Clinical Response","author":"EADIE M.J.","year":"1981"},{"doi-asserted-by":"publisher","key":"e_1_2_1_9_1","DOI":"10.1016\/0010-468X(84)90022-9"},{"doi-asserted-by":"publisher","key":"e_1_2_1_10_1","DOI":"10.1111\/j.2042-7158.1984.tb04917.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_11_1","DOI":"10.1007\/BF03189703"},{"doi-asserted-by":"publisher","key":"e_1_2_1_12_1","DOI":"10.2165\/00003088-198106060-00002"},{"doi-asserted-by":"publisher","key":"e_1_2_1_13_1","DOI":"10.1007\/BF01059058"},{"doi-asserted-by":"publisher","key":"e_1_2_1_14_1","DOI":"10.1007\/BF01065659"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3565(25)30657-9","article-title":"Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat","volume":"199","author":"KLOTZ U.","year":"1976","journal-title":"J. Pharmacol. Exp. Ther"},{"doi-asserted-by":"publisher","key":"e_1_2_1_16_1","DOI":"10.1002\/cpt196673362"},{"key":"e_1_2_1_17_1","first-page":"1","volume-title":"Proc. 2nd World Conf. Clin. Pharmacol. Ther., 1983","author":"LEVY G.","year":"1984"},{"doi-asserted-by":"publisher","key":"e_1_2_1_18_1","DOI":"10.1111\/j.1528-1157.1986.tb05731.x"},{"volume-title":"A User's Manual for NONLIN and Associated Programs, Research Biostatistics","year":"1974","author":"METZLER C.M.","key":"e_1_2_1_19_1"},{"doi-asserted-by":"publisher","key":"e_1_2_1_20_1","DOI":"10.1002\/cpt1979253358"},{"doi-asserted-by":"publisher","key":"e_1_2_1_21_1","DOI":"10.1097\/00000542-197909000-00011"},{"key":"e_1_2_1_22_1","first-page":"433","volume-title":"Experimental Models of Epilepsy\u2014a Manual for the Laboratory Worker","author":"SWINYARD E.A.","year":"1972"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-3565(25)26434-5","article-title":"Effect of brief restraint on the convulsive threshold of mice","volume":"138","author":"SWINYARD E.A.","year":"1962","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_1_24_1","first-page":"111","volume-title":"Antiepileptic Drugs","author":"SWINYARD E.A.","year":"1982"},{"doi-asserted-by":"publisher","key":"e_1_2_1_25_1","DOI":"10.1016\/0014-2999(85)90675-2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_26_1","DOI":"10.1016\/0920-1211(89)90039-9"},{"doi-asserted-by":"publisher","key":"e_1_2_1_27_1","DOI":"10.1016\/0022-5193(68)90188-4"},{"doi-asserted-by":"publisher","key":"e_1_2_1_28_1","DOI":"10.1152\/ajplegacy.1962.202.2.379"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1990.tb14653.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1990.tb14653.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:22:51Z","timestamp":1743808971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1990.tb14653.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.1111\/j.1476-5381.1990.tb14653.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1990.tb14653.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"type":"print","value":"0007-1188"},{"type":"electronic","value":"1476-5381"}],"subject":[],"published":{"date-parts":[[1990,1]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}